Serotonin transporter gene associated with lithium prophylaxis in mood disorders

被引:0
|
作者
Serretti A. [1 ]
机构
[1] Department of Psychiatry, Vita-Salute University, San Raffaele Institute, Milan
关键词
Bipolar disorder; Follow-up studies; Lithium; Pharmacogeneties;
D O I
10.1038/sj.tpj.6500006
中图分类号
学科分类号
摘要
The aim of this study was to investigate the possible association between the functional polymorphism in the upstream regulatory region of the serotonin transporter gene (5-HTTLPR) and the prophylactic efficacy of lithium in mood disorders. Two hundred and one subjects affected by bipolar (n = 167) and major depressive (n = 34) disorder were followed prospectively for an average of 58.2 months and were typed for their 5-HTTLPR variant using polymerase chain reaction techniques. 5-HTTLPR variants were associated with lithium outcome (F = 5.35; df = 2,198; P = 0.005). Subjects with the s/s variant showed a worse response compared to both l/s and I/I variants. Consideration of possible stratification effects such as sex, polarity, age at onset, duration of lithium treatment and previous episodes did not influence the observed association. 5-HTTLPR variants may be a possible influencing factor for the prophylactic efficacy of lithium in mood disorders. © 2001 Nature Publishing Group All rights reserved.
引用
收藏
页码:71 / 77
页数:6
相关论文
共 50 条
  • [41] Serotonin transporter gene moderates associations between mood, memory and hippocampal volume
    Price, Jenessa S.
    Strong, Judith
    Eliassen, James
    McQueeny, Tim
    Miller, Megan
    Padula, Claudia B.
    Shear, Paula
    Lisdahl, Krista
    BEHAVIOURAL BRAIN RESEARCH, 2013, 242 : 158 - 165
  • [42] The serotonin transporter gene polymorphism is not associated with smoking behavior
    Trummer, O.
    Koeppel, H.
    Wascher, T. C.
    Gruenbacher, G.
    Gutjahr, M.
    Stanger, O.
    Ramschak-Schwarzer, S.
    Boehm, B. O.
    Winkelmann, B. R.
    Maerz, W.
    Renner, W.
    PHARMACOGENOMICS JOURNAL, 2006, 6 (06): : 397 - 400
  • [43] CARBAMAZEPINE IN THE PROPHYLAXIS OF MOOD DISORDERS
    STUPPAECK, C
    BARNAS, C
    MILLER, C
    SCHWITZER, J
    FLEISCHHACKER, WW
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1990, 10 (01) : 39 - 42
  • [44] Lithium prophylaxis of mood disorders: Efficacy, acceptability and anti-suicidal effects
    Geddes, J
    Burgess, S
    Hawton, K
    Townsend, E
    Jamison, K
    Goodwin, G
    JOURNAL OF AFFECTIVE DISORDERS, 2002, 68 (01) : 83 - 83
  • [45] The serotonin transporter in psychiatric disorders
    Shamsi, Mohd A.
    Jahan, Sultana
    PSYCHIATRIC ANNALS, 2008, 38 (04) : 285 - 291
  • [46] The serotonin transporter gene polymorphisms are associated with suicidal behaviour in alcoholism.: Impulsivity vs mood variation as intermediate phenotype?
    Gorwood, P
    Hamon, M
    Boni, C
    Adès, J
    EUROPEAN PSYCHIATRY, 2000, 15 : 76 - 76
  • [47] Self-esteem in remitted patients with mood disorders is not associated with the dopamine receptor D4 and the serotonin transporter genes
    Serretti, A
    Macciardi, F
    Di Bella, D
    Catalano, M
    Smeraldi, E
    PSYCHIATRY RESEARCH, 1998, 80 (02) : 137 - 144
  • [48] Serotonin-transporter gene variants in affective and schizophrenic disorders.
    Schoeler, A
    Putzhammer, A
    Rohrmeier, T
    Sartor, H
    Heyne, C
    Eichhammer, P
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1998, 81 (06): : 505 - 505
  • [49] Association between anxiety disorders and a functional polymorphism in the serotonin transporter gene
    Ohara, K
    Nagai, M
    Suzuki, Y
    Ochiai, M
    Ohara, K
    PSYCHIATRY RESEARCH, 1998, 81 (02) : 277 - 279
  • [50] Review: Lithium is associated with adverse events in patients with mood disorders
    Preda, Adrian
    ANNALS OF INTERNAL MEDICINE, 2012, 157 (02)